Welcome
-
Home
-
Register
-
Login
-
Help/FAQ
-
0 items
Search
Enter keywords, a title or
a report id number below.
In All Categories
---------------------
Telecom & Computing
Business & Finance
Mfg & Construction
Pharma & Healthcare
Consumer & Retail
Gov & Public Sector
Energy & Transport
Country Reports
Company Reports
---------------------
Transcripts
Advanced
The Biochemistry of Drug Metabolism: Two Volume Set
Direct to Consumer Communication in the Pharmaceutical Industry
The Royalty Rate Report 2010: A Comprehensive Assessment of ...
Select a currency for use throughout the site
Australia Dollars
Canada Dollars
Euro
Japan Yen
Sweden Kroner
Switzerland Francs
UK Pounds
US Dollars
Viewing a category
Home
- Pharmaceuticals
Companies
Drug Delivery
Markets
OTC
Respiratory
Vitamins
Drug Discovery
Technology
E-Healthcare
Central Nervous System
Generics
Genomics
Immune Disorders
Infectious Diseases
Oncology
Pharmacoeconomics
Women's Health
Cardiovascular
Fast Facts
Analgesics
Sort by
Report Name ASC
Report Name DESC
Report Price ASC
Report Price DESC
Sorted by Date Added
Substance Abuse Treatment for Youth and Adults: Clinician's Guide to Evidence-Based Practice
John Wiley and Sons Ltd, Sep 2009, Pages: 432
State-of-the-art, empirical support for the treatmentof substance abuse Part of the Clinician's Guide to Evidence-Based Practice Series, Substance Abuse Treatment for Youth and Adults provides busy me...
The Sugar Code: Fundamentals of Glycosciences
John Wiley and Sons Ltd, Sep 2009, Pages: 597
A reader friendly, strategically structured introduction to glycosciences, guiding from the basics of the sugar alphabet and pertinent aspects of chemical/natural glycosylation to functional carbohydr...
Global Stem Cell and Advanced Technologies Market
MarketsandMarkets.com, Nov 2009, Pages: 229
The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies The benefits of stem cell therapy are attracting an increasing number of patients The product...
Opportunity Analysis of H1N1 (swine flu) Vaccination Market
MarketsandMarkets.com, Nov 2009, Pages: 126
H1N1 Influenza A (2009) is the first pandemic influenza of 21st century affecting more than more than four lac people in more than 180 countries across the globe in 2009 The flu broke in Mexico in the...
China Pharma Outsourcing Annual Review 2009
JZMed Inc., Nov 2009, Pages: 162
It has been well recognized that 2009 is a rough year to all types of industries worldwide The financial crisis has significantly altered both pharmaceutical and biotechnology industries on global sca...
Hypertension: Treatments and Prescribing Practices - A Global Survey
BioPharm Reports (VennBio Ltd.), Nov 2009, Pages: 225
This report presents the findings of a global survey on current treatments and prescribing practices for Hypertension These findings were made following the participation of more than 280 clinics worl...
Nigeria Pharmaceuticals and Healthcare Report Q1 2010
Business Monitor International, Nov 2009, Pages: 90
Nigeria Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with indepe...
Neurological Disease: Early-Stage R&D and Dealmaking
Decision Resources, Inc., Aug 2009, Pages: 25
How can early-stage R&D efforts be positioned to tap the remaining opportunity in the neurology drug market? Although brimming with potential, neurology drug development is also rife with unique chall...
Kenya Pharmaceuticals and Healthcare Report Q1 2010
Business Monitor International, Nov 2009, Pages: 73
Kenya Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independ...
Strategies for Building Early-Stage Pharmaceutical Pipelines Through External Sources
Decision Resources, Inc., July 2009, Pages: 29
Under tremendous pressure to refuel dwindling development pipelines and improve R&D productivity, pharmaceutical companies are seeking external sources of products and innovation Biotech companies off...
Argentina Pharmaceuticals and Healthcare Report Q1 2010
Business Monitor International, Nov 2009, Pages: 89
Argentina Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with inde...
Poland Pharmaceuticals and Healthcare Report Q1 2010
Business Monitor International, Nov 2009, Pages: 82
Poland Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with indepen...
Pharmaceutical Market Access, Pricing, and Reimbursement News in the Third Quarter of 2009
Decision Resources, Inc., Oct 2009, Pages: 40
The third quarter of 2009 saw a heated debate in the United States over healthcare reform, the publication of a report on a European investigation of the pharmaceutical industry, the election of new g...
Thailand Pharmaceuticals and Healthcare Report Q1 2010
Business Monitor International, Nov 2009, Pages: 79
Thailand Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with indep...
Australia Pharmaceuticals and Healthcare Report Q1 2010
Business Monitor International, Nov 2009, Pages: 94
Australia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with inde...
The Pricing and Reimbursement Environment for Neurology Drugs
Decision Resources, Inc., Aug 2009, Pages: 64
Neurological disorders will impose a growing social and financial burden on the major pharmaceutical markets as the elderly population in these countries increases steadily Governments and other payer...
Pharmaceutical Market Access, Pricing, and Reimbursement News in the Second Quarter of 2009
Decision Resources, Inc., Aug 2009, Pages: 40
The second quarter of 2009 saw steady progress toward healthcare reform in the United States and action in several of the world’s other major pharmaceutical markets to curb pharmaceutical expenditures...
Biomarker and Diagnostic Opportunities in Clinical Research for Neurological Diseases
Decision Resources, Inc., Oct 2009, Pages: 32
Biomarkers and imaging tools are enabling technologies in today’s clinical research efforts for neurological diseases Whether to improve upon existing methods for monitoring disease progression or to ...
Uncovering Biomarker and Diagnostic Opportunities in Immune and Inflammatory Diseases
Decision Resources, Inc., Aug 2009, Pages: 28
Despite the robust drug market for immune and inflammatory diseases and their high prevalence, diagnostics associated with these diseases do not constitute a large marketplace Although researchers are...
The Royalty Rate Report 2010: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
PharmaVentures, Jan 2010, Pages: 160
The Definitive Industry Reference, this report is a “must read” for anyone involved in deal making who wants to get the maximum value from their next deal "The report sets out to give the reader a ful...
Results:
First
-
Prev
-
1
-
2
-
3
-
4
-
5
-
6
-
Next
-
Last
Top of page
All rights reserved. © Copyright 2009 Research and Markets
1
Terms and conditions
Privacy Policy
Publishers
Employment Opportunities
Site Map
Link to us
Webmaster